Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Latest Articles

  • Open Access
    FAM32A Suppression Decreases 5-Fluorouracil-induced Apoptosis and Is Associated With Poor Prognosis in Gastric Cancer
    YUYA AGATSUMA, DAI SHIMIZU, SHINICHI UMEDA, HARUYOSHI TANAKA, NORIFUMI HATTORI, MASAMICHI HAYASHI, MITSURO KANDA, CHIE TANAKA, GORO NAKAYAMA, MICHITAKA FUJIWARA and YASUHIRO KODERA
    Cancer Genomics & Proteomics January 2025, 22 (1) 55-69; DOI: https://doi.org/10.21873/cgp.20487
  • Open Access
    Regulation and Function of CCL2 and N-Myc in Retinoic Acid-treated Neuroblastoma Cells
    NANKE MURRA, NINA SOPHIE POMMERT, BERIT SCHMIDT, REEMA SAMI ISSA, MEIKE KAEHLER, HENRIKE BRUCKMUELLER, VERA TIM, INGOLF CASCORBI and VICKI WAETZIG
    Cancer Genomics & Proteomics January 2025, 22 (1) 90-102; DOI: https://doi.org/10.21873/cgp.20490
  • Open Access
    RFC3 Knockdown Decreases Cervical Cancer Cell Proliferation, Migration and Invasion
    JAE WOONG KOH and SEON-JOO PARK
    Cancer Genomics & Proteomics January 2025, 22 (1) 127-135; DOI: https://doi.org/10.21873/cgp.20493
  • Open Access
    Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors
    TOMOYUKI ISHIGURO, KAZUYUKI TAKEDA, DAISUKE TAKAYANAGI, EMIKO MURA, RISAKO SUZUKI, TOSHIAKI TSURUI, NANA IRIGUCHI, YUYA HIRASAWA, RYOTARO OHKUMA, MASAHIRO SHIMOKAWA, HIROTSUGU ARIIZUMI, YUTARO KUBOTA, ATSUSHI HORIIKE, MASAHIKO IZUMIZAKI, SATOSHI WADA, KIYOSHI YOSHIMURA, ROBERT M. HOFFMAN and TAKUYA TSUNODA
    Cancer Genomics & Proteomics January 2025, 22 (1) 1-12; DOI: https://doi.org/10.21873/cgp.20481
  • Open Access
    Immunohistochemical Analysis of a1-Acid Glycoprotein and Tumor Associated Macrophages in Clear Cell Renal Cell Carcinoma
    AYANO EZAKI, HIROMU YANO, CHENG PAN, YUKIO FUJIWARA, TOSHIKI ANAMI, YUKI IBE, YOUJIRO OZAKI, HIDEKAZU NISHIZAWA, TAKANOBU MOTOSHIMA, JUNJI YATSUDA, HIROSHI WATANABE, TORU MARUYAMA, TORU TAKEO, TOMOMI KAMBA and YOSHIHIRO KOMOHARA
    Cancer Genomics & Proteomics January 2025, 22 (1) 103-111; DOI: https://doi.org/10.21873/cgp.20491
  • Open Access
    Contribution of Cyclin Dependent Kinase Inhibitor 1A Genotypes to Childhood Acute Lymphocytic Leukemia Risk in Taiwan
    CHAO-CHUN CHEN, CHUNG-LIN TSAI, JEN-SHENG PEI, HUEY-EN TZENG, PEI-CHEN HSU, DA-CHUAN CHENG, JIUNN-CHERNG LIN, CHIA-WEN TSAI, DA-TIAN BAU and WEN-SHIN CHANG
    Cancer Genomics & Proteomics January 2025, 22 (1) 46-54; DOI: https://doi.org/10.21873/cgp.20486
  • Open Access
    G Protein-coupled Estrogen Receptor 1 (GPER1) Regulates Expression of SERPINE1/PAI-1 and Inhibits Tumorigenic Potential of Cervical Squamous Cell Carcinoma Cells In Vitro
    LINEA RÖRIG, SOPHIA RUCKRIEGL, JULIA GALLWAS and CARSTEN GRÜNDKER
    Cancer Genomics & Proteomics January 2025, 22 (1) 13-23; DOI: https://doi.org/10.21873/cgp.20482
  • Open Access
    Two Different NF1 Pathogenic Variants in a Family With Neurofibromatosis Type 1
    TABEA I. HARTUNG, LAN KLUWE, REINHARD E. FRIEDRICH and SAID C. FARSCHTSCHI
    Cancer Genomics & Proteomics January 2025, 22 (1) 41-45; DOI: https://doi.org/10.21873/cgp.20485
  • Open Access
    Serum Exosomes Expressing CD9, CD63 and HER2 From Breast-Cancer Patients Decreased After Surgery of the Primary Tumor: A Potential Biomarker of Tumor Burden
    SACHIKO INUBUSHI, TOMONARI KUNIHISA, MARINA KUNIYASU, SHOTARO INOUE, MAYUKO YAMAMOTO, YUJI YAMASHITA, MAYUKO MIKI, SACHIKO MIZUMOTO, MOTOI BABA, ROBERT M. HOFFMAN and HIROKAZU TANINO
    Cancer Genomics & Proteomics November 2024, 21 (6) 580-584; DOI: https://doi.org/10.21873/cgp.20474
  • Open Access
    Cordycepin Activates Autophagy to Suppress FGF9-induced TM3 Mouse Leydig Progenitor Cell Proliferation
    SU-ZHEN WU, YU-YAN LAN, CHIN-YING CHEN, LI-CHING CHEN and BU-MIIN HUANG
    Cancer Genomics & Proteomics November 2024, 21 (6) 630-644; DOI: https://doi.org/10.21873/cgp.20479

Pages

  • Previous
  • Next
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 2539
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire